Microbiotica

Microbiotica

Private
CambridgeHealthcare & Life Scienceshttps://microbiotica.com

Last Round

Series B

Mar 7, 2022

Total Funding Raised

$82.6M

Momentum Score

25 /100

Company Overview

Microbiotica is a biotechnology company that develops live bacterial therapeutics and biomarkers based on microbiome science.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share

AI Layer

Non-AI

Keywords

live biotherapeutic productsLBPsmicrobiome therapeuticsimmuno-oncologyinflammatory bowel diseaseIBDmicrobiome discovery platformbugs as drugsgut microbiomeulcerative colitismelanomadrug discoveryprecision medicinebacterial consortiaoral therapeutics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Microbiotica Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Microbiotica Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series BMar 7, 2022
Series AOct 24, 2018
SeedDec 19, 2016

Key People

Founding team and executive leadership

Tim Sharpington

Chief Executive Officer

Executive Team

Stuart Gibson

Chief Financial Officer

Executive Team

Robert Tansley

Chief Medical Officer, Board Member

Executive Team

Microbiotica Investors

Notable investors and investment history

InvestorRounds
IP GroupSeries B, Seed
Flerie InvestSeries B
British Patient CapitalSeries B
Cambridge Innovation CapitalSeries B, Seed
Seventure PartnersSeries B, Series A

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 12, 2026

    Monthly visitors grew 101% MoM.

  • Jun 10, 2025

    Dr. Robert Tansley appointed as new Chief Medical Officer.

Microbiotica Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Microbiotica Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Microbiotica's valuation, stock price, and market status.

Firmographic Details

HeadquartersCambridge
Employee Range55
Year Founded2016
Last FundingMar 7, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.